0 NASDAQ Companies - March 1, 2019Core-Mark Announces 2018 Fourth Quarter and Full Year Financial ResultsRead More
0 NASDAQ Companies - March 1, 2019Dermira Presents New Data from its Phase 3 Clinical Program Evaluating Glycopyrronium Tosylate (QBREXZA™ (glycopyrronium) cloth) in Patients with Primary Axillary HyperhidrosisRead More
0 NASDAQ Companies - March 1, 2019Krystal Biotech to Present at the Cowen and Company 39th Annual Health Care ConferenceRead More
0 NASDAQ Companies - March 1, 2019CHMP Recommends Zynquista™ (Sotagliflozin) for the Treatment of Adults With Type 1 DiabetesRead More
0 NASDAQ Companies - March 1, 2019Outlook Therapeutics Submits IND Application for ONS-5010 to the FDARead More
0 NASDAQ Companies - March 1, 2019Principia Biopharma Presents Phase 1 Clinical Data from CNS Penetrating BTK Inhibitor Candidate PRN2246/SAR442168 at ACTRIMS 2019Read More
0 NASDAQ Companies - March 1, 2019Bionano Genomics Launches New Capabilities of the Saphyr System to Significantly Increase Its Cost Effectiveness, Speed and Ease of Use for Whole Human Genome Structural Variation Analysis and Digital CytogeneticsRead More
0 TSX Venture News - March 1, 2019Manitou Gold Announces Closing of Strategic Partnership with GoldSpot Discoveries Inc, Private Placement and Investment and Related AgreementsRead More
0 NASDAQ Companies - March 1, 2019Akcea and Ionis Receive Positive EU CHMP Opinion for WAYLIVRATM (volanesorsen)Read More
